Found (985) clinical trials

The primary goal is to address several key treatment and management issues surrounding patients with either AIS or ICH on anticoagulant therapy. In particular, attention will be focused on coagulation tests, utilization of thrombolytic therapy for AIS, treatment patterns and clinical outcomes for AIS and ICH patients on anticoagulant therapy.

MaRISS is a prospective observational study to define the 90-day outcomes of patients with mild and/or rapidly improving stroke by a telephone-based assessment of stroke outcomes based on established and validated measures including the mRS, BI, SIS-16 and EuroQOL. The efficacy and safety outcomes of patients with mild and improving ...

The purpose of this Tandem Lesion Registry is to collect information (data) on a technique to remove the blood clot and restore blood flow during your stroke. The registry will also collect data on other standard of care treatments and increase our understanding that the treatment has on stroke patients.

You are being invited to take part in a research study about meditation after stroke. Meditation can be defined as an activity where you practice focusing your attention. Mantra meditation is a type of meditation in which a word or syllable is repeated. The researchers would like to see if ...

Researchers at the University of Kentucky College of Health Sciences are inviting couples to participate in a study on aphasia involving collaborative problem-solving. The study involves simple screening tests of cognitive and language skills, an interview, and a questionnaire. Volunteers need to come to UK for 4 sessions lasting up ...

Stroke represents the fourth leading cause of death in industrialized nations, after heart disease, cancer, and chronic lower respiratory disease. Each year approximately 795,000 people experience a new or recurrent stroke (ischemic or hemorrhagic) in the U.S. Also, in 2009, stroke caused approximately 1 of every 18 deaths in the ...

You are being asked to participate in a clinical research study because in the last 48 hours you were diagnosed with either an acute ischemic stroke or transient ischemic attack (TIA). The purpose of this study is to determine if the study drug, BMS-986141, is safe and prevents a future ...